Enter your email to read this article
Read news on any topic, in one place, from publishers like The Economist, FT, Bloomberg and more.
Bloomberg

Cough Syrup Linked to 66 Gambian Deaths May Be in Other Countries, WHO Warns

The logo for the World Health Organization (WHO) WHO Info application is displayed on a computer screen in an arranged photograph taken in Bern, Switzerland, on Tuesday, March 31, 2020. The Covid-19 pandemic has triggered a seismic wave of health awareness and anxiety, which is energizing a new category of virus-fighting tech and apps. Photographer: Stefan Wermuth/Bloomberg (Bloomberg)

The World Health Organization has warned that a deadly batch of cough mixture connected to the deaths of dozens of children in Gambia may have been distributed to other countries.

The agency on Wednesday placed a medical product alert on cough and cold syrups made by India’s Maiden Pharmaceuticals Ltd., which have been potentially linked to acute kidney injuries and 66 deaths among children in the tiny West African nation, WHO Director General Tedros Adhanom Ghebreyesus said during a media briefing. 

Four contaminated Maiden products were found in a laboratory analysis to contain “unacceptable amounts” of diethylene glycol and ethylene glycol, the WHO said. Tedros added that the global health body is conducting further investigations with the company and Indian regulators, while recommending countries remove the treatments from circulation.

Calls to the drugmaker’s corporate office in New Delhi weren’t answered and the company didn’t immediately respond to emails seeking comment. 

Maiden Pharma manufactured and exported these products only to Gambia, according to a statement from India’s health ministry late Thursday, adding that none of these four drugs were sold in India. 

“It is a usual practice that the importing country tests these imported products on quality parameters, and satisfies itself” before deciding to release them for usage in the country, the ministry said in the statement. India is also awaiting WHO’s analysis showing “exact one to one causal relation” of deaths in Gambia to these treatments, it said.

The deaths shine a spotlight on India’s $42 billion drugmaking industry, which has been heavily promoted by Prime Minister Narendra Modi as the “pharmacy of the world.”

India supplies many of the cheap, generic drugs sold in American pharmacies and hundreds of countries globally. But treatments produced in the South Asian nation have been the source of multiple manufacturing scandals in recent years, including the export of tainted heart pills.

Closely-held Maiden Pharma has been making and supplying medical products for more than 30 years and has a presence across multiple countries in Africa, Asia, Eastern Europe, the Middle East and Russia, according to its website. 

©2022 Bloomberg L.P.

Related Stories
Cough syrups linked to 66 child deaths in The Gambia
Indian pharmaceutical company under investigation over four products it manufactures and exports
From analysis to the latest developments in health, read the most diverse news in one place.
CDSCO orders probe as WHO links 66 deaths in Gambia to India-made cough syrup
The Central Drugs Standard Control Ogranisation has formed a committee to examine the facts pertaining to the cough syrups, the manufacturing license of the company
Rash of child deaths in Gambia linked to cough syrups made in India -WHO
The deaths of dozens of young children in Gambia from acute kidney injuries may be linked to contaminated cough and cold syrups made by an Indian drug manufacturer, the World Health Organization said on Wednesday.
WHO issues alert as over 60 deaths of children in Gambia linked to cough syrup
The deaths of dozens of young children in Gambia from acute kidney injuries may be linked to contaminated cough and cold syrups made by an Indian drug manufacturer, the World Health Organization said on Wednesday.
Cough syrup warning: WHO issues urgent alert about medicine linked to deaths of 66 kids
World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said four cold and cough syrups have been potentially linked with acute kidney injuries and the deaths of 66 children
One place to find news on any topic, from hundreds of sites.
None of four cough syrups linked to death of 66 children in Gambia available for sale in India, say distributors
The Government of India has ordered a probe after WHO issued a warning about the drugs manufactured by Haryana-based pharmaceutical firm